Search results for "multiparameter flow cytometry"

showing 2 items of 2 documents

Old and new immunophenotypic markers in multiple myeloma for discrimination of responding and relapsing patients: The importance of "normal" residual…

2014

Background Multiple myeloma is an incurable disease characterized by proliferation of clonal malignant plasma cells (CPCs), which can be immunophenotypically distinguished from polyclonal plasma cells (PPCs) by multiparameter flow cytometry (MFC). The utility of PPCs analysis in detecting prognostic and predictive information is still a matter of debate. Methods: we tested the ability of 11 MFC markers in detecting differences in the immunophenotype of CPCs and PPCs among patients in various disease stages; we verified if these markers could be associated with disease stage/response to therapy despite the role of clinical parameters. Results: significant changes in the expression of markers…

MaleHistologyIntegrin alpha4Antigens CD19Plasma CellsAntineoplastic AgentsSettore MED/42 - Igiene Generale E ApplicataImmunophenotypingMonoclonal gammopathieRecurrenceMultiple myelomaHumansAgedNeoplasm StagingSettore MED/04 - Patologia GeneraleMonoclonal gammopathies; Multiparameter flow cytometry; Multiple myeloma; Cell Biology; HistologyCell BiologyMiddle AgedCD58 AntigensFlow CytometryPrognosisCD56 AntigenClone CellsMultiparameter flow cytometryTreatment OutcomeGene Expression RegulationLeukocyte Common AntigensRegression AnalysisFemaleBiomarkers
researchProduct

MGUS and multiple myeloma: looking for “new” markers and exploring the interaction with the bone marrow microenvironment.

Settore MED/04 - Patologia Generalemultiparameter flow cytometry multiple myeloma MGUS
researchProduct